US Patent 12083112 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Eisai Inc

Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Contact Supplier

Evonik Health Care is the innovation hub for leading life science companies

Contact Supplier

Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

Contact Supplier

Axplora is your partner of choice for complex APIs.

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-2-2026-02-09

Eisai Inc

VIRTUAL BOOTH, Contact Details

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 301 News #PharmaBuzz

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
301 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

4 All APIs, 2 USDMF, 2 KDMF

4 All APIs
2 USDMF
2 KDMF

DEVELOPMENTS

298 Drugs in Development

298 Drugs in Development

FINISHED DOSAGE FORMULATIONS

85 FDF Dossiers, 23 FDA Orange Book, 41 Europe, 21 Canada

85 FDF Dossiers
23 FDA Orange Book
41 Europe
21 Canada

INSPECTIONS & REGISTRATIONS

6 FDA

6 FDA

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

4 All

01 4EISAI INC

filter Patent Number Reset all filters

4 All

01 412083112

API Patent Reset all filters

4 All

01 4Blank

FDF Patent Reset all filters

4 All

01 4Blank

filter Expiration Date Reset all filters

4 All

01 42036-03-03

01

EISAI INC

LENVATINIB MESYLATE

BePharma

Not Confirmed

EISAI INC

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-03-03

LENVATINIB MESYLATE

US Patent Number : 12083112

Drug Substance Claim :

Drug Product Claim :

Application Number : 206947

Patent Use Code : U-3997

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-03-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

EISAI INC

LENVATINIB MESYLATE

BePharma

Not Confirmed

EISAI INC

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-03-03

LENVATINIB MESYLATE

US Patent Number : 12083112

Drug Substance Claim :

Drug Product Claim :

Application Number : 206947

Patent Use Code : U-3997

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-03-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

EISAI INC

LENVATINIB MESYLATE

BePharma

Not Confirmed

EISAI INC

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-03-03

LENVATINIB MESYLATE

US Patent Number : 12083112

Drug Substance Claim :

Drug Product Claim :

Application Number : 206947

Patent Use Code : U-3996

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-03-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

EISAI INC

LENVATINIB MESYLATE

BePharma

Not Confirmed

EISAI INC

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-03-03

LENVATINIB MESYLATE

US Patent Number : 12083112

Drug Substance Claim :

Drug Product Claim :

Application Number : 206947

Patent Use Code : U-3996

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-03-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.